申请人:——
公开号:US20030195200A1
公开(公告)日:2003-10-16
The present invention relates to compounds of the general formula (I)
1
The compounds are useful in the treatment and/or prevention of conditions mediated by nuclear receptors, in particular the Peroxisome Proliferator-Activated Receptors (PPAR).
本发明涉及一般式(I)的化合物,这些化合物在治疗和/或预防由核受体介导的疾病方面具有用处,特别是过氧化物酶体增殖物激活受体(PPAR)。